Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Net Income (Loss)	$ 10,041,312	$ 8,730,003
Adjustments to reconcile net income to net cash provided by operating activities:
Accretion of deferred loan origination fees and other discounts	(369,971)	(477,756)
Paid-in-kind interest	(1,595,058)	(3,008,593)
(Benefit) provision for current expected credit losses	(1,073,276)	380,279
Change in unrealized gain on investments		75,604
Realized gain on debt securities, at fair value		(72,428)
Amortization of debt issuance costs	110,309	90,915
Stock based compensation	649,312	531,293
Changes in operating assets and liabilities:
Interest receivable	(62,075)	77,288
Other receivables and assets, net	(116,936)	(97,151)
Interest reserve	(771,066)	1,444,982
Related party payables	(456,894)	(296,790)
Related party receivables	2,141,780	(85,129)
Proceeds from the redemption of debt securities, at fair value		839,094
Management and incentive fees payable	(1,127,625)	(1,424,347)
Accounts payable and accrued expenses	255,356	210,608
Net cash provided by operating activities	7,625,168	6,917,872
Cash flows from investing activities
Issuance of and fundings of loans held for investment	(3,663,318)	(22,380,807)
Principal repayment of loans held for investment	9,170,628	3,663,452
Net cash provided by/(used in) investing activities	5,507,310	(18,717,355)
Cash flows from financing activities
Proceeds from sale of common stock	1,033,474	9,811,862
Proceeds from borrowings on revolving loan	16,000,000	28,000,000
Repayment of borrowings on revolving loan	(33,000,000)	(12,750,000)
Dividends paid to common shareholders	(13,605,154)	(13,866,656)
Payment of debt issuance costs	0	(49,738)
Payment of offering costs	(82,069)	(339,912)
Net cash (used in)/provided by financing activities	(29,653,749)	10,805,556
Net decrease in cash and cash equivalents	(16,521,271)	(993,927)
Cash and cash equivalents, beginning of period	26,400,448	7,898,040
Cash and cash equivalents, end of period	9,879,177	6,904,113
Supplemental disclosure of non-cash financing and investing activities
Interest reserve withheld from funding of loans	20,714	2,032,688
OID withheld from funding of loans held for investment	181,800	105,081
Dividends declared and not yet paid	9,820,079	9,007,244
Subscription receivable from sale of common stock		4,472,690
Payable for investment purchased	500,000
Supplemental information:
Interest paid during the period	$ 1,740,547	$ 1,786,333